News & Events

Check out the latest news and events in the Wockhardt USA community.

Recent News
11
Aug

Wockhardt Receives US FDA Approval for Antibiotic Injection

Posted on in News
Pharmaceutical and biotechnology major Wockhardt has received approval from the United States Food & Drug Administration (US FDA) for an ANDA for 1gm, and 2gm injections of Oxacillin. Oxacillin i... Continue reading
27
Jul

Wockhardt Q3FY17 Net Sales at Rs.995 crore, EBITDA at Rs. 18 crore

Posted on in News
Wockhardt Limited, the Pharmaceutical and Biotechnology major, reported its 3rd Quarter results for Financial Year 2017, today. The Company’s performance during the quarter was affected by subdued bu... Continue reading
27
Jul

Wockhardt Receives Acknowledgement of Its Breakthrough Superdrug Antibiotic Wck 5222 For Phase III Clinical Trial From Us FDA

Posted on in News
WOCKHARDT RECEIVES ACKNOWLEDGEMENT OF ITS BREAKTHROUGH SUPERDRUG ANTIBIOTIC WCK 5222 FOR PHASE III CLINICAL TRIAL FROM US FDA In a recent meeting between Wockhardt Research team and US FDA New Drug A... Continue reading
27
Jul

Wockhardt Q4FY17 Net Sales at Rs.864 crore and FY16-17 at Rs. 4,015 crore

Posted on in News
Wockhardt Limited, the Pharmaceutical and Biotechnology major, reported its 4th Quarter and annual results for Financial Year 2017, today. Update on Business : During the year, certain polito-economi... Continue reading
03
Jul

Wockhardt Receives US FDA Approval for Eye Drop for treating Ophthalmic Allergies Mumbai

Posted on in News
India July 3, 2017 Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for its ANDA for 0.1% ophthalmic solutio... Continue reading